BioCentury | Nov 26, 2018
Distillery Therapeutics
Transplant
...of organ rejection. TARGET/MARKER/PATHWAY: Apolipoprotein A-1 (APOA1; apoa); mammalian target of rapamycin (mTOR; FRAP; RAFT1); tumor necrosis factor receptor-associated factor...
...Quang Icahn School of Medicine at Mount Sinai Apolipoprotein A-1 (APOA1) (apo(a)) Mammalian target of rapamycin (mTOR) (FRAP) (RAFT1) Tumor necrosis factor (TNF) receptor-associated factor...
...Quang Icahn School of Medicine at Mount Sinai Apolipoprotein A-1 (APOA1) (apo(a)) Mammalian target of rapamycin (mTOR) (FRAP) (RAFT1) Tumor necrosis factor (TNF) receptor-associated factor...